Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

A new study has identified the protein ADAMTS5 as playing a crucial role in the spread of ovarian cancer cells, offering a ...

This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine ...

The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ...

Northwestern Medicine scientists have uncovered new details about the genetic structure of ovarian cancer stem cells, ...

Get Instant Summarized Text (Gist) A Phase 3 trial demonstrated that a cancer stem cell test, ChemoID, can effectively select treatments for patients with platinum-resistant ovarian cancer, leading to ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women ...